Vitamin D, Cancer Risk, and Mortality

Abbas, 2009, Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a german case–control study, International Journal of Cancer, 124, 250, 10.1002/ijc.23904 Abbas, 2008, The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status, Cancer Epidemiology, Biomarkers & Prevention, 17, 1339, 10.1158/1055-9965.EPI-08-0162 Ahn, 2010, Genome-wide association study of circulating vitamin D levels, Human Molecular Genetics, 19, 2739, 10.1093/hmg/ddq155 Anderson, 2011, Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among Caucasian women in Ontario, Cancer Epidemiology, Biomarkers & Prevention, 20, 1708, 10.1158/1055-9965.EPI-11-0300 Anderson, 2013, Genetic variants in vitamin D pathway genes and risk of pancreas cancer; results from a population-based case–control study in Ontario, Canada, PLoS One, 8, e66768, 10.1371/journal.pone.0066768 Anderson, 2003, Implementation of the women's health initiative study design, Annals of Epidemiology, 13, S5, 10.1016/S1047-2797(03)00043-7 Anic, 2012, An exploratory analysis of common genetic variants in the vitamin D pathway including genome-wide associated variants in relation to glioma risk and outcome, Cancer Causes & Control, 23, 1443, 10.1007/s10552-012-0018-7 Anic, 2014, Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer, PLoS One, 9, e102966, 10.1371/journal.pone.0102966 Arai, 2001, The polymorphism in the caudal-related homeodomain protein cdx-2 binding element in the human vitamin D receptor gene, Journal of Bone and Mineral Research, 16, 1256, 10.1359/jbmr.2001.16.7.1256 Arjumand, 2012, Vitamin D receptor FokI and BsmI gene polymorphism and its association with grade and stage of renal cell carcinoma in North Indian population, Tumour Biology, 33, 23, 10.1007/s13277-011-0236-8 Armstrong, 2004, How sun exposure causes skin cancer: An epidemiological perspective, 89 Autier, 2014, Vitamin D status and ill health: A systematic review, The Lancet Diabetes & Endocrinology, 2, 76, 10.1016/S2213-8587(13)70165-7 Autier, 2012, A systematic review: Influence of vitamin D supplementation on serum 25-hydroxyvitamin D concentration, The Journal of Clinical Endocrinology and Metabolism, 97, 2606, 10.1210/jc.2012-1238 Avenell, 2012, Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial), The Journal of Clinical Endocrinology and Metabolism, 97, 614, 10.1210/jc.2011-1309 Bai, 2012, Vitamin D receptor gene polymorphisms and colorectal cancer risk: A systematic meta-analysis, World Journal of Gastroenterology, 18, 1672, 10.3748/wjg.v18.i14.1672 Bai, 2009, Association of vitamin D receptor polymorphisms with the risk of prostate cancer in the Han population of Southern China, BMC Medical Genetics, 10, 10.1186/1471-2350-10-125 Barroso, 2008, Genetic analysis of the vitamin D receptor gene in two epithelial cancers: Melanoma and breast cancer case–control studies, BMC Cancer, 8, 385, 10.1186/1471-2407-8-385 Bentley, 2012, Vitamin D receptor polymorphisms in colorectal cancer in New Zealand: An association study, The New Zealand Medical Journal, 125, 47 Bhaskaran, 2014, Body-mass index and risk of 22 specific cancers: A population-based cohort study of 5.24 million UK adults, Lancet, 384, 755, 10.1016/S0140-6736(14)60892-8 Bikle, 1989, Free, and not total, 1,25-dihydroxyvitamin D regulates 25-hydroxyvitamin D metabolism by keratinocytes, Endocrinology, 124, 649, 10.1210/endo-124-2-649 Bolland, 2011, Calcium and vitamin D supplements and health outcomes: A reanalysis of the Women's Health Initiative (WHI) limited-access data set, American Journal Of Clinical Nutrition, 94, 1144, 10.3945/ajcn.111.015032 Bouillon, 2008, Vitamin D and human health: Lessons from vitamin D receptor null mice, Endocrine Reviews, 29, 726, 10.1210/er.2008-0004 Brunner, 2011, The effect of calcium plus vitamin D on risk for invasive cancer: Results of the women's health initiative (WHI) calcium plus vitamin D randomized clinical trial, Nutrition and Cancer, 63, 827, 10.1080/01635581.2011.594208 Buyru, 2003, Vitamin D receptor gene polymorphisms in breast cancer, Experimental & Molecular Medicine, 35, 550, 10.1038/emm.2003.72 Caini, 2014, Vitamin D and melanoma and non-melanoma skin cancer risk and prognosis: A comprehensive review and meta-analysis, European Journal of Cancer (Oxford, England: 1990), 50, 2649, 10.1016/j.ejca.2014.06.024 Carter, 2011, Accuracy of 25-hydroxyvitamin D assays: Confronting the issues, Current Drug Targets, 12, 19, 10.2174/138945011793591608 Cawthon, 2010, Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men, The Journal of Clinical Endocrinology and Metabolism, 95, 4625, 10.1210/jc.2010-0638 Chen, 2013, 1,25-dihydroxyvitamin D promotes negative feedback regulation of TLR signaling via targeting microRNA-155-SOCS1 in macrophages, Journal of Immunology (Baltimore, Maryland: 1950), 190, 3687 Chlebowski, 2008, Calcium plus vitamin D supplementation and the risk of breast cancer, Journal of the National Cancer Institute, 100, 1581, 10.1093/jnci/djn360 Chowdhury, 2014, Vitamin D and risk of cause specific death: Systematic review and meta-analysis of observational cohort and randomised intervention studies, BMJ (Clinical Research Ed.), 348, g1903 Cicek, 2006, Vitamin D receptor genotypes/haplotypes and prostate cancer risk, Cancer Epidemiology, Biomarkers & Prevention, 15, 2549, 10.1158/1055-9965.EPI-06-0409 Clendenen, 2008, Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer, Cancer Letters, 260, 209, 10.1016/j.canlet.2007.11.002 Colston, 1981, 1,25-dihydroxyvitamin D3 and malignant melanoma: The presence of receptors and inhibition of cell growth in culture, Endocrinology, 108, 1083, 10.1210/endo-108-3-1083 Curran, 1999, Association of a vitamin D receptor polymorphism with sporadic breast cancer development, International Journal of Cancer, 83, 723, 10.1002/(SICI)1097-0215(19991210)83:6<723::AID-IJC4>3.0.CO;2-3 DeLuca, 2004, Overview of general physiologic features and functions of vitamin D, The American Journal of Clinical Nutrition, 80, 1689S, 10.1093/ajcn/80.6.1689S Denzer, 2011, Vitamin D receptor (VDR) polymorphisms and skin cancer: A systematic review, Dermato-Endocrinology, 3, 205, 10.4161/derm.16519 Doorenbos, 2009, Possible renoprotection by vitamin D in chronic renal disease: Beyond mineral metabolism, Nature Reviews Nephrology, 5, 691, 10.1038/nrneph.2009.185 Dorjgochoo, 2011, Common genetic variants in the vitamin D pathway including genome-wide associated variants are not associated with breast cancer risk among chinese women, Cancer Epidemiology, Biomarkers & Prevention, 20, 2313, 10.1158/1055-9965.EPI-11-0704 Drake, 2010, Vitamin D insufficiency and prognosis in non-Hodgkin’s lymphoma, Journal of Clinical Oncology, 28, 4191, 10.1200/JCO.2010.28.6674 Durrin, 1999, Vitamin D receptor 3'-untranslated region polymorphisms: Lack of effect on mRNA stability, Biochimica et Biophysica Acta, 1453, 311, 10.1016/S0925-4439(99)00007-1 Durup, 2012, A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: The CopD study, The Journal of Clinical Endocrinology and Metabolism, 97, 2644, 10.1210/jc.2012-1176 Dusso, 2005, Vitamin D, American Journal of Physiology. Renal Physiology, 289, F8, 10.1152/ajprenal.00336.2004 Eaton, 2011, Prospective association of vitamin D concentrations with mortality in postmenopausal women: Results from the women's health initiative (WHI), The American Journal of Clinical Nutrition, 94, 1471, 10.3945/ajcn.111.017715 Eisman, 1987, Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3, Cancer Research, 47, 21 El Ghissassi, 2009, A review of human carcinogens—Part D: Radiation, The Lancet Oncology, 10, 751, 10.1016/S1470-2045(09)70213-X Elamin, 2011, Vitamin D and cardiovascular outcomes: A systematic review and meta-analysis, The Journal of Clinical Endocrinology and Metabolism, 96, 1931, 10.1210/jc.2011-0398 Engelman, 2008, Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in hispanic and African Americans, The Journal of Clinical Endocrinology and Metabolism, 93, 3381, 10.1210/jc.2007-2702 Evans, 1996, Vitamin D receptor and growth inhibition by 1,25-dihydroxyvitamin D3 in human malignant melanoma cell lines, The Journal of Surgical Research, 61, 127, 10.1006/jsre.1996.0092 Fang, 2011, Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer, PLoS One, 6, e18625, 10.1371/journal.pone.0018625 Farrell, 2012, State-of-the-art vitamin D assays: A comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods, Clinical Chemistry, 58, 531, 10.1373/clinchem.2011.172155 Fedirko, 2012, Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European populations, Cancer Epidemiology, Biomarkers & Prevention, 21, 582, 10.1158/1055-9965.EPI-11-1065 Fiscella, 2011, Racial disparity in death from colorectal cancer: Does vitamin D deficiency contribute?, Cancer, 117, 1061, 10.1002/cncr.25647 Flohil, 2010, Vitamin D-binding protein polymorphisms are not associated with development of (multiple) basal cell carcinomas, Experimental Dermatology, 19, 1103, 10.1111/j.1600-0625.2010.01139.x Flugge, 2007, Vitamin D receptor haplotypes protect against development of colorectal cancer, European Journal of Clinical Pharmacology, 63, 997, 10.1007/s00228-007-0367-4 Freedman, 2009, Vitamin D and cancer mortality, Cancer Epidemiology, Biomarkers & Prevention, 18, 359, 10.1158/1055-9965.EPI-08-0633 Freedman, 2010, Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988–2006), Cancer Research, 70, 8587, 10.1158/0008-5472.CAN-10-1420 Freedman, 2007, Prospective study of serum vitamin D and cancer mortality in the United States, Journal of the National Cancer Institute, 99, 1594, 10.1093/jnci/djm204 Fu, 2013, Epigenetic regulation of BMP2 by 1,25-dihydroxyvitamin D3 through DNA methylation and histone modification, PLoS One, 8, e61423, 10.1371/journal.pone.0061423 Fuhrman, 2013, Sunlight, polymorphisms of vitamin D-related genes and risk of breast cancer, Anticancer Research, 33, 543 Gandini, 2011, Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma, International Journal of Cancer, 128, 1414, 10.1002/ijc.25439 Gandini, 2014, Vitamin D receptor polymorphisms and cancer, Advances in Experimental Medicine and Biology, 810, 69 Gandini, 2009, Vitamin D and skin cancer: A meta-analysis, European Journal of Cancer (Oxford, England: 1990), 45, 634, 10.1016/j.ejca.2008.10.003 Gandini, 2005, Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure, European Journal of Cancer (Oxford, England: 1990), 41, 45, 10.1016/j.ejca.2004.10.016 Gapska, 2009, Vitamin D receptor variants and breast cancer risk in the polish population, Breast Cancer Research and Treatment, 115, 629, 10.1007/s10549-008-0107-1 Garland, 1989, Serum 25-hydroxyvitamin D and colon cancer: Eight-year prospective study, Lancet, 2, 1176, 10.1016/S0140-6736(89)91789-3 Garland, 2006, The role of vitamin D in cancer prevention, American Journal of Public Health, 96, 252, 10.2105/AJPH.2004.045260 Giovannucci, 2005, The epidemiology of vitamin D and cancer incidence and mortality: A review (United States), Cancer Causes & Control, 16, 83, 10.1007/s10552-004-1661-4 Giovannucci, 2006, Prospective study of predictors of vitamin D status and cancer incidence and mortality in men, Journal of the National Cancer Institute, 98, 451, 10.1093/jnci/djj101 Gnagnarella, 2014, Vitamin D receptor polymorphism FokI and cancer risk: A comprehensive meta-analysis, Carcinogenesis, 35, 1913, 10.1093/carcin/bgu150 Goodwin, 2009, Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer, Journal of Clinical Oncology, 27, 3757, 10.1200/JCO.2008.20.0725 Grant, 2013, Vitamin D receptor (VDR) polymorphisms and risk of ovarian cancer in Caucasian and African American women, Gynecologic Oncology, 129, 173, 10.1016/j.ygyno.2012.12.027 Grimes, 2006, Are statins analogues of vitamin D?, Lancet, 368, 83, 10.1016/S0140-6736(06)68971-X Gross, 1998, The vitamin D receptor gene start codon polymorphism: A functional analysis of FokI variants, Journal of Bone and Mineral Research, 13, 1691, 10.1359/jbmr.1998.13.11.1691 Gu, 2014, Vitamin D receptor gene polymorphisms and esophageal cancer risk in a Chinese population: A negative study, Medical Oncology (Northwood, London, England), 31, 10.1007/s12032-013-0827-x Gugatschka, 2011, Vitamin D status is associated with disease-free survival and overall survival time in patients with squamous cell carcinoma of the upper aerodigestive tract, European Archives of Oto-Rhino-Laryngology, 268, 1201, 10.1007/s00405-010-1481-y Gunduz, 2012, Association of vitamin D receptor gene polymorphisms with colon cancer, Genetic Testing and Molecular Biomarkers, 16, 1058, 10.1089/gtmb.2012.0044 Guy, 2004, Vitamin D receptor gene polymorphisms and breast cancer risk, Clinical Cancer Research, 10, 5472, 10.1158/1078-0432.CCR-04-0206 Han, 2006, Risk factors for skin cancers: A nested case–control study within the nurses’ health study, International Journal of Epidemiology, 35, 1514, 10.1093/ije/dyl197 Han, 2007, Polymorphisms in the MTHFR and VDR genes and skin cancer risk, Carcinogenesis, 28, 390, 10.1093/carcin/bgl156 Hansen, 1998, Down-regulation of laminin-binding integrins by 1 alpha,25-dihydroxyvitamin D3 in human melanoma cells in vitro, Cell Adhesion and Communication, 5, 109, 10.3109/15419069809040285 Heist, 2008, Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer, Journal of Clinical Oncology, 26, 5596, 10.1200/JCO.2008.18.0406 Hewison, 2012, An update on vitamin D and human immunity, Clinical Endocrinology, 76, 315, 10.1111/j.1365-2265.2011.04261.x Hine, 1994, Seasonal variation in serum 25-hydroxy vitamin D3 does not affect 1,25-dihydroxy vitamin D, Annals of Clinical Biochemistry, 31, 31, 10.1177/000456329403100105 Hiraki, 2013, Genetic predictors of circulating 25-hydroxyvitamin D and risk of colorectal cancer, Cancer Epidemiology, Biomarkers & Prevention, 22, 2037, 10.1158/1055-9965.EPI-13-0209 Holick, 1996, Vitamin D and bone health, The Journal of Nutrition, 126, 1159S, 10.1093/jn/126.suppl_4.1159S Holick, 2002, Vitamin D: The underappreciated D-lightful hormone that is important for skeletal and cellular health, Current Opinion in Endocrinology, Diabetes, and Obesity, 9, 87, 10.1097/00060793-200202000-00011 Holick, 2007, Vitamin D deficiency, The New England Journal of Medicine, 357, 266, 10.1056/NEJMra070553 Hollis, 2005, Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: Implications for establishing a new effective dietary intake recommendation for vitamin D, The Journal of Nutrition, 135, 317, 10.1093/jn/135.2.317 Holt, 2009, Vitamin D pathway gene variants and prostate cancer risk, Cancer Epidemiology, Biomarkers & Prevention, 18, 1929, 10.1158/1055-9965.EPI-09-0113 Huang, 2013, The cdx-2 polymorphism in the VDR gene is associated with increased risk of cancer: A meta-analysis, Molecular Biology Reports, 40, 4219, 10.1007/s11033-013-2503-9 Hughes, 2011, Variation in the vitamin D receptor gene is not associated with risk of colorectal cancer in the Czech Republic, Journal of Gastrointestinal Cancer, 42, 149, 10.1007/s12029-010-9168-6 Hutchinson, 2010, Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: The tromso study, European Journal of Endocrinology/European Federation of Endocrine Societies, 162, 935, 10.1530/EJE-09-1041 IARC, 1992, IARC monographs on the evaluation of carcinogenic risks to humans. Solar and ultraviolet radiation, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans/World Health Organization, International Agency for Research on Cancer, 55, 1 IARC, 2008 Ingles, 1997, Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: Implications for association studies, Cancer Epidemiology, Biomarkers & Prevention, 6, 93 Jacobs, 2011, Vitamin D and breast cancer recurrence in the women's healthy eating and living (WHEL) study, The American Journal of Clinical Nutrition, 93, 108, 10.3945/ajcn.2010.30009 Jenab, 2009, Vitamin D receptor and calcium sensing receptor polymorphisms and the risk of colorectal cancer in european populations, Cancer Epidemiology, Biomarkers & Prevention, 18, 2485, 10.1158/1055-9965.EPI-09-0319 John, 2005, Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer, Cancer Research, 65, 5470, 10.1158/0008-5472.CAN-04-3134 Karami, 2013, Pesticide exposure and inherited variants in vitamin D pathway genes in relation to prostate cancer, Cancer Epidemiology, Biomarkers & Prevention, 22, 1557, 10.1158/1055-9965.EPI-12-1454 Karami, 2008, Vitamin D receptor polymorphisms and renal cancer risk in central and eastern Europe, Journal of Toxicology and Environmental Health, Part A, 71, 367, 10.1080/15287390701798685 Kim, 2014, Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: A meta-analysis, British Journal of Cancer, 110, 2772, 10.1038/bjc.2014.175 Kostner, 2012, Association of genetic variants of the vitamin D receptor (VDR) with cutaneous squamous cell carcinomas (SCC) and basal cell carcinomas (BCC): A pilot study in a german population, Anticancer Research, 32, 327 Kostner, 2009, The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: A review of the literature, Anticancer Research, 29, 3511 Krause, 2012, Vitamin D status and mortality of german hemodialysis patients, Anticancer Research, 32, 391 Kricker, 2006, Does sunlight have a beneficial influence on certain cancers?, Progress in Biophysics and Molecular Biology, 92, 132, 10.1016/j.pbiomolbio.2006.02.015 Lappe, 2007, Vitamin D and calcium supplementation reduces cancer risk: Results of a randomized trial, The American Journal of Clinical Nutrition, 85, 1586, 10.1093/ajcn/85.6.1586 Lauridsen, 2005, Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of gc (vitamin D-binding protein): A cross-sectional study on 595 early postmenopausal women, Calcified Tissue International, 77, 15, 10.1007/s00223-004-0227-5 Lesiak, 2011, An enhanced risk of basal cell carcinoma is associated with particular polymorphisms in the VDR and MTHFR genes, Experimental Dermatology, 20, 800, 10.1111/j.1600-0625.2011.01328.x Li, 2009, Vitamin D receptor gene polymorphisms and the risk of colorectal cancer in a chinese population, Digestive Diseases and Sciences, 54, 634, 10.1007/s10620-008-0375-y Li, 2007, A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer, PLoS Medicine, 4, e103, 10.1371/journal.pmed.0040103 Li, 2013, Association of vitamin D receptor gene polymorphisms with pancreatic cancer: A pilot study in a north China population, Oncology Letters, 5, 1731, 10.3892/ol.2013.1215 Liao, 2015, Impact of serum vitamin D level on risk of bladder cancer: A systemic review and meta-analysis, Tumour Biology, 36, 1567, 10.1007/s13277-014-2728-9 Lim, 2006, Cancer survival is dependent on season of diagnosis and sunlight exposure, International Journal of Cancer, 119, 1530, 10.1002/ijc.22052 Liu, 2013, Prospective analysis of vitamin D and endometrial cancer risk, Annals of Oncology, 24, 687, 10.1093/annonc/mds509 Liu, 2005, Polymorphisms of vitamin D receptor gene protect against the risk of head and neck cancer, Pharmacogenetics and Genomics, 15, 159, 10.1097/01213011-200503000-00004 Lurie, 2011, Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: Pooled analysis in five studies within the ovarian cancer association consortium, International Journal of Cancer, 128, 936, 10.1002/ijc.25403 Lurie, 2007, Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk, Cancer Epidemiology, Biomarkers & Prevention, 16, 2566, 10.1158/1055-9965.EPI-07-0753 Mahmoudi, 2011, Start codon FokI and intron 8 BsmI variants in the vitamin D receptor gene and susceptibility to colorectal cancer, Molecular Biology Reports, 38, 4765, 10.1007/s11033-010-0613-1 Maki, 2011, Effects of vitamin D supplementation on 25-hydroxyvitamin D, high-density lipoprotein cholesterol, and other cardiovascular disease risk markers in subjects with elevated waist circumference, International Journal of Food Sciences and Nutrition, 62, 318, 10.3109/09637486.2010.536146 Manson, 2012, The VITamin D and OmegA-3 TriaL (VITAL): Rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease, Contemporary Clinical Trials, 33, 159, 10.1016/j.cct.2011.09.009 McCullough, 2007, Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: A nested case–control study, Breast Cancer Research, 9, R9, 10.1186/bcr1642 McKay, 2009, Vitamin D receptor polymorphisms and breast cancer risk: Results from the national cancer institute breast and prostate cancer cohort consortium, Cancer Epidemiology, Biomarkers & Prevention, 18, 297, 10.1158/1055-9965.EPI-08-0539 Melamed, 2008, 25-hydroxyvitamin D levels and the risk of mortality in the general population, Archives of Internal Medicine, 168, 1629, 10.1001/archinte.168.15.1629 Meyer, 2011, Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients, International Journal of Cancer, 128, 1741, 10.1002/ijc.25496 Mezawa, 2010, Serum vitamin D levels and survival of patients with colorectal cancer: Post-hoc analysis of a prospective cohort study, BMC Cancer, 10, 10.1186/1471-2407-10-347 Michaelsson, 2010, Plasma vitamin D and mortality in older men: A community-based prospective cohort study, The American Journal of Clinical Nutrition, 92, 841, 10.3945/ajcn.2010.29749 Mikhak, 2007, Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk, The Prostate, 67, 911, 10.1002/pros.20570 Mittal, 2007, Association of vitamin-D receptor (fok-I) gene polymorphism with bladder cancer in an indian population, BJU International, 99, 933, 10.1111/j.1464-410X.2007.06657.x Moan, 2008, Addressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposure, Proceedings of the National Academy of Sciences of the United States of America, 105, 668, 10.1073/pnas.0710615105 Mocellin, 2008, Vitamin D receptor polymorphisms and the risk of cutaneous melanoma: A systematic review and meta-analysis, Cancer, 113, 2398, 10.1002/cncr.23867 Mondul, 2013, Genetic variation in the vitamin D pathway in relation to risk of prostate cancer—Results from the breast and prostate cancer cohort consortium, Cancer Epidemiology, Biomarkers & Prevention, 22, 688, 10.1158/1055-9965.EPI-13-0007-T Mondul, 2012, Serum vitamin D and risk of bladder cancer in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial, Cancer Epidemiology, Biomarkers & Prevention, 21, 1222, 10.1158/1055-9965.EPI-12-0439 Mondul, 2014, Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma, International Journal of Cancer, 134, 2699, 10.1002/ijc.28596 Mondul, 2012, Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer, British Journal of Cancer, 107, 1589, 10.1038/bjc.2012.417 Morrison, 1992, Contribution of trans-acting factor alleles to normal physiological variability: Vitamin D receptor gene polymorphism and circulating osteocalcin, Proceedings of the National Academy of Sciences of the United States of America, 89, 6665, 10.1073/pnas.89.15.6665 Murtaugh, 2006, Vitamin D receptor gene polymorphisms, dietary promotion of insulin resistance, and colon and rectal cancer, Nutrition and Cancer, 55, 35, 10.1207/s15327914nc5501_5 Muscogiuri, 2012, Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives, Nutrition, Metabolism, and Cardiovascular Diseases, 22, 81, 10.1016/j.numecd.2011.11.001 Newton-Bishop, 2009, Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma, Journal of Clinical Oncology, 27, 5439, 10.1200/JCO.2009.22.1135 Ng, 2011, Vitamin D status in patients with stage IV colorectal cancer: Findings from intergroup trial N9741, Journal of Clinical Oncology, 29, 1599, 10.1200/JCO.2010.31.7255 Ng, 2009, Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer, British Journal of Cancer, 101, 916, 10.1038/sj.bjc.6605262 Obara, 2007, Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population, International Journal of Urology, 14, 483, 10.1111/j.1442-2042.2007.01771.x Ochs-Balcom, 2008, Association of vitamin D receptor gene variants, adiposity and colon cancer, Carcinogenesis, 29, 1788, 10.1093/carcin/bgn166 Ojha, 2007, Vitamin D for cancer prevention: Valid assertion or premature anointment?, The American Journal of Clinical Nutrition, 86, 1804, 10.1093/ajcn/86.6.1804 Osborne, 2002, Vitamin D and systemic cancer: Is this relevant to malignant melanoma?, The British Journal of Dermatology, 147, 197, 10.1046/j.1365-2133.2002.04960.x Pardanani, 2011, Vitamin D insufficiency in myeloproliferative neoplasms and myelodysplastic syndromes: Clinical correlates and prognostic studies, American Journal of Hematology, 86, 1013, 10.1002/ajh.22181 Pena-Chilet, 2013, rs12512631 on the group specific complement (vitamin D-binding protein GC) implicated in melanoma susceptibility, PLoS One, 8, e59607, 10.1371/journal.pone.0059607 Penna-Martinez, 2009, Vitamin D receptor polymorphisms in differentiated thyroid carcinoma, Thyroid, 19, 623, 10.1089/thy.2008.0388 Pike, 1997 Pilz, 2008, Low serum levels of 25-hydroxyvitamin D predict fatal cancer in patients referred to coronary angiography, Cancer Epidemiology, Biomarkers & Prevention, 17, 1228, 10.1158/1055-9965.EPI-08-0002 Pilz, 2013, Vitamin D and cancer mortality: Systematic review of prospective epidemiological studies, Anti-Cancer Agents in Medicinal Chemistry, 13, 107, 10.2174/187152013804487407 Pilz, 2010, Vitamin D deficiency and myocardial diseases, Molecular Nutrition & Food Research, 54, 1103 Pilz, 2011, Vitamin D supplementation: A promising approach for the prevention and treatment of strokes, Current Drug Targets, 12, 88, 10.2174/138945011793591563 Pilz, 2011, Vitamin D, cardiovascular disease and mortality, Clinical Endocrinology, 75, 575, 10.1111/j.1365-2265.2011.04147.x Pilz, 2009, Epidemiology of vitamin D insufficiency and cancer mortality, Anticancer Research, 29, 3699 Pinczewski, 2010, The potential role of vitamin D in the progression of benign and malignant melanocytic neoplasms, Experimental Dermatology, 19, 860, 10.1111/j.1600-0625.2010.01169.x Poole, 2006, Reduced vitamin D in acute stroke, Stroke, 37, 243, 10.1161/01.STR.0000195184.24297.c1 Powe, 2013, Vitamin D-binding protein and vitamin D status of black Americans and white Americans, The New England Journal of Medicine, 369, 1991, 10.1056/NEJMoa1306357 Poynter, 2010, Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: Results from the colon cancer family registry, Cancer Epidemiology, Biomarkers & Prevention, 19, 525, 10.1158/1055-9965.EPI-09-0662 Purdue, 2007, Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin lymphoma, Cancer Causes & Control, 18, 989, 10.1007/s10552-007-9039-z Purdue, 2007, Vitamin D receptor gene polymorphisms and risk of non-Hodgkin’s lymphoma, Haematologica, 92, 1145, 10.3324/haematol.11053 Raimondi, 2009, Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk, Carcinogenesis, 30, 1170, 10.1093/carcin/bgp103 Raimondi, 2014, BsmI polymorphism of vitamin D receptor gene and cancer risk: A comprehensive meta-analysis, Mutation Research, 769, 17, 10.1016/j.mrfmmm.2014.06.001 Randerson-Moor, 2009, Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case–control comparisons and a meta-analysis of published VDR data, European Journal of Cancer (Oxford, England: 1990), 45, 3271, 10.1016/j.ejca.2009.06.011 Ren, 2012, Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer, Journal of Translational Medicine, 10, 10.1186/1479-5876-10-16 Saliba, 2012, The risk of all-cause mortality is inversely related to serum 25(OH)D levels, The Journal of Clinical Endocrinology and Metabolism, 97, 2792, 10.1210/jc.2012-1747 Sarkissyan, 2014, Vitamin D receptor FokI gene polymorphisms may be associated with colorectal cancer among African American and hispanic participants, Cancer, 120, 1387, 10.1002/cncr.28565 Schabas, 2008, Artifact in the control group undermines the conclusions of a vitamin D and cancer study, The American Journal of Clinical Nutrition, 87, 792, 10.1093/ajcn/87.3.792 Schottker, 2014, Vitamin D and mortality: Meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States, BMJ (Clinical Research Ed.), 348, g3656 Schwalfenberg, 2011, A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency, Molecular Nutrition & Food Research, 55, 96, 10.1002/mnfr.201000174 Scragg, 1981, Seasonality of cardiovascular disease mortality and the possible protective effect of ultra-violet radiation, International Journal of Epidemiology, 10, 337, 10.1093/ije/10.4.337 Semba, 2010, Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults, European Journal of Clinical Nutrition, 64, 203, 10.1038/ejcn.2009.140 Serrano, 2015, Meta-analysis on vitamin D receptor and cancer risk: Focus on the role of TaqI, ApaI, and Cdx2 polymorphisms, European Journal of Cancer Prevention, 10.1097/CEJ.0000000000000132 Shafia, 2013, Role of vitamin D receptor (VDR) polymorphisms in susceptibility to multiple myeloma in ethnic kashmiri population, Blood Cells, Molecules & Diseases, 51, 56, 10.1016/j.bcmd.2013.02.001 Shahbazi, 2013, BsmI but not FokI polymorphism of VDR gene is contributed in breast cancer, Medical Oncology (Northwood, London, England), 30, 10.1007/s12032-012-0393-7 Shanafelt, 2011, Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia, Blood, 117, 1492, 10.1182/blood-2010-07-295683 Shui, 2012, Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: A prospective nested case–control study, Journal of the National Cancer Institute, 104, 690, 10.1093/jnci/djs189 Sinotte, 2009, Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women, The American Journal of Clinical Nutrition, 89, 634, 10.3945/ajcn.2008.26445 Sinotte, 2008, Vitamin D receptor polymorphisms (FokI, BsmI) and breast cancer risk: Association replication in two case–control studies within French Canadian population, Endocrine Related Cancer, 15, 975, 10.1677/ERC-08-0056 Slatter, 2001, Variants of the VDR gene and risk of colon cancer (United States), Cancer Causes & Control, 12, 359, 10.1023/A:1011280518278 Slattery, 2009, Colon tumor mutations and epigenetic changes associated with genetic polymorphism: Insight into disease pathways, Mutation Research, 660, 12, 10.1016/j.mrfmmm.2008.10.001 Slominski, 2004, Melanin pigmentation in mammalian skin and its hormonal regulation, Physiological Reviews, 84, 1155, 10.1152/physrev.00044.2003 Smedby, 2011, Vitamin D receptor genotypes, ultraviolet radiation exposure, and risk of non-Hodgkin lymphoma, American Journal of Epidemiology, 173, 48, 10.1093/aje/kwq340 Sood, 2007, Dietary vitamin D and decreases in cancer rates: Canada as the national experiment, The American Journal of Clinical Nutrition, 86, 1549, 10.1093/ajcn/86.5.1549 Souberbielle, 2010, Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice, Autoimmunity Reviews, 9, 709, 10.1016/j.autrev.2010.06.009 Speeckaert, 2006, Biological and clinical aspects of the vitamin D binding protein (gc-globulin) and its polymorphism, Clinica Chimica Acta, 372, 33, 10.1016/j.cca.2006.03.011 Szendroi, 2011, The role of vitamin D, estrogen, calcium sensing receptor genotypes and serum calcium in the pathogenesis of prostate cancer, The Canadian Journal of Urology, 18, 5710 Tang, 2009, Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: A meta-analysis, Breast Cancer Research and Treatment, 117, 391, 10.1007/s10549-008-0262-4 Tang, 2012, Vitamin D in cutaneous carcinogenesis: Part I, Journal of the American Academy of Dermatology, 67, 10.1016/j.jaad.2012.07.022 Theodoratou, 2008, Modification of the inverse association between dietary vitamin D intake and colorectal cancer risk by a FokI variant supports a chemoprotective action of vitamin D intake mediated through VDR binding, International Journal of Cancer, 123, 2170, 10.1002/ijc.23769 Tjellesen, 1983, Vitamin D metabolites in normal subjects during one year. A longitudinal study, Scandinavian Journal of Clinical and Laboratory Investigation, 43, 85, 10.3109/00365518309168226 Toptas, 2013, The vitamin D receptor (VDR) gene polymorphisms in Turkish brain cancer patients, BioMed Research International, 2013, 295791, 10.1155/2013/295791 Torkko, 2008, VDR and SRD5A2 polymorphisms combine to increase risk for prostate cancer in both non-hispanic white and Hispanic white men, Clinical Cancer Research, 14, 3223, 10.1158/1078-0432.CCR-07-4894 Touvier, 2011, Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk, Cancer Epidemiology, Biomarkers & Prevention, 20, 1003, 10.1158/1055-9965.EPI-10-1141 Tretli, 2009, Association between serum 25(OH)D and death from prostate cancer, British Journal of Cancer, 100, 450, 10.1038/sj.bjc.6604865 Tretli, 2012, Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: A population-based study, Cancer Causes & Control, 23, 363, 10.1007/s10552-011-9885-6 Trivedi, 2003, Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: Randomised double blind controlled trial, BMJ (Clinical Research Ed.), 326, 469, 10.1136/bmj.326.7387.469 Tworoger, 2009, Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies, Cancer Research, 69, 1885, 10.1158/0008-5472.CAN-08-3515 Uitterlinden, 2004, Vitamin D receptor gene polymorphisms in relation to vitamin D related disease states, The Journal of Steroid Biochemistry and Molecular Biology, 89–90, 187, 10.1016/j.jsbmb.2004.03.083 Vrieling, 2011, Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: A prospective patient cohort study, Breast Cancer Research, 13, R74, 10.1186/bcr2920 Wactawski-Wende, 2006, Calcium plus vitamin D supplementation and the risk of colorectal cancer, The New England Journal of Medicine, 354, 684, 10.1056/NEJMoa055222 Wang, 2014, Plasma free 25-hydroxyvitamin D, vitamin D binding protein, and risk of breast cancer in the nurses’ health study II, Cancer Causes & Control, 25, 819, 10.1007/s10552-014-0383-5 Wang, 2008, Vitamin D deficiency and risk of cardiovascular disease, Circulation, 117, 503, 10.1161/CIRCULATIONAHA.107.706127 Wang, 2010, Common genetic determinants of vitamin D insufficiency: A genome-wide association study, Lancet, 376, 180, 10.1016/S0140-6736(10)60588-0 Weinstein, 2013, Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer, International Journal of Cancer, 132, 2940, 10.1002/ijc.27969 Weinstein, 2015, Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the prostate, lung, colorectal and ovarian cancer screening trial, International Journal of Cancer, 136, E654, 10.1002/ijc.29157 Whitfield, 2001, Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene, Molecular and Cellular Endocrinology, 177, 145, 10.1016/S0303-7207(01)00406-3 Wortsman, 2000, Decreased bioavailability of vitamin D in obesity, The American Journal of Clinical Nutrition, 72, 690, 10.1093/ajcn/72.3.690 Yin, 2011, Meta-analysis: Circulating vitamin D and ovarian cancer risk, Gynecologic Oncology, 121, 369, 10.1016/j.ygyno.2011.01.023 Yin, 2013, Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: A systematic review and meta-analysis, Preventive Medicine, 57, 753, 10.1016/j.ypmed.2013.08.026 Yudoh, 1999, 1alpha,25-dihydroxyvitamin D3 inhibits in vitro invasiveness through the extracellular matrix and in vivo pulmonary metastasis of B16 mouse melanoma, The Journal of Laboratory and Clinical Medicine, 133, 120, 10.1016/S0022-2143(99)90004-5 Zhao, 2014, Polymorphisms in the vitamin D receptor (VDR) genes and skin cancer risk in european population: A meta-analysis, Archives of Dermatological Research, 306, 545, 10.1007/s00403-014-1464-8 Zhou, 2007, Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients, Journal of Clinical Oncology, 25, 479, 10.1200/JCO.2006.07.5358 Zhou, 2013, Association between vitamin D receptor gene Cdx2 polymorphism and breast cancer susceptibility, Tumour Biology, 34, 3437, 10.1007/s13277-013-0919-4 Zhou, 2012, GC Glu416Asp and Thr420Lys polymorphisms contribute to gastrointestinal cancer susceptibility in a Chinese population, International Journal of Clinical and Experimental Medicine, 5, 72 Zittermann, 2012, Vitamin D deficiency and mortality risk in the general population: A meta-analysis of prospective cohort studies, The American Journal of Clinical Nutrition, 95, 91, 10.3945/ajcn.111.014779 Zittermann, 2005, Putting cardiovascular disease and vitamin D insufficiency into perspective, The British Journal of Nutrition, 94, 483, 10.1079/BJN20051544